Ontogenesis of thyroid function and interactions with maternal function

Endocrine Development

Volumn 10, Issue , 2007, Pages 86-98

  Obregon, M ^a   Calvo, R ^a   Escobar Del Rey, F ^a   Morreale De Escobar, G ^a  

^a CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE;

ANIMAL; EMBRYO; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; METABOLISM; NEWBORN; PHYSIOLOGY; PREGNANCY; PREMATURITY; PRENATAL DEVELOPMENT; REVIEW; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; THYROID GLAND;

ANIMALS; EMBRYO; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; THYROID GLAND; THYROID HORMONES;

EID: 35148887345     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000106821     Document Type: Review

References (33)

1. Santisteban P: Development and anatomy of the hypothalamus-pituitary- thyroid axis; in Braverman LF, Utiger RD (eds): Werner and Ingbar's The Thyroid. A Fundamental and Clinical Text, ed 9. Philadelphia, Lippincott Williams & Wilkins, 2005, pp 8-25.
2. Morreale de Escobar G, Obregón MJ, Escobar del Rey F: Is neuropsychological development related to maternal hypothyroidism, or to maternal hypothyroxinemia? J Clin Endocrinol Metab 2000;85:3975-3987.
3. Ruiz de Ona C, Morreale de Escobar G, Calvo R, Escobar del Rey F, Obregon MJ: Thyroid hormones and 5′-deiodinase in the rat fetus late in gestation: effects of maternal hypothyroidism. Endocrinology 1991;128:422-432.
4. Obregon MJ, Ruiz de Ona C, Calvo R, Escobar del Rey F, Morreale de Escobar G: Outer ring iodothyronine deiodinases and thyroid hormone economy: responses to iodine deficiency in the rat fetus and neonate. Endocrinology 1991;129:2663-2673.
5. Ruiz de Oña C, Obregón MJ, Escobar del Rey F, Morreale de Escobar G: Developmental changes in rat brain 5′-deiodinase and thyroid hormones during the fetal period: the effects of fetal hypothyroidism and maternal thyroid hormones. Pediatr Res 1988;24:588-594.
6. Galton VA: The roles of the iodothyronine deiodinases in mammalian development. Thyroid 2005;15:823-834.
7. Huang SA, Dorfman DM, Genest DR, Salvatore D, Larsen PR: Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab 2003;88:1384-1388.
8. Morreale de Escobar G, Obregón MJ, Escobar del Rey F: Maternal thyroid hormones early in pregnancy and fetal brain development. Best Practice Res Clin Endocrinol Metab 2004;18: 225-248.
9. Morreale de Escobar G, Obregon MJ, Escobar del Rey F: Role of thyroid hormone during early brain development. Eur J Endocrinol 2004;151(suppl 3):U25-U37.
10. Morreale de Escobar G, Pastor R, Obregón MJ, Escobar del Rey F: Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues. Endocrinology 1985;117:1890-1901.
11. Bernal J, Pekonen F: Ontogenesis of the nuclear 3,5,3′- triiodothyroxine receptor in the human fetal brain. Endocrinology 1984;114:677-679.
12. Bernal J, Pérez-Castillo A, Pans T, Pekonen F: Ontogenesis of thyroid hormone receptor; in Labrie F, Proulx L (eds): Endocrinology. Amsterdam, Elsevier Science Publisher, 1984, pp 977-980.
13. Iskaros J, Pickard M, Evans I, Sinha A, Hardiman P, Ekins R: Thyroid hormone receptor gene expression in first trimester human fetal brain. Journal of Clinical Endocrinology and Metabolism 2000;85:2620-2623.
14. Calvo R, Obregon MJ, Ruiz de Oña C, Escobar del Rey F, Morreale de Escobar G: Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3′-triiodothyronine in the protection of the fetal brain. J Clin Invest 1990;86:889-899.
15. Morreale de Escobar G, Calvo R, Obregon MJ, Escobar del Rey F: Homeostasis of brain T3 in rat fetuses and their mothers: effects of thyroid status and iodine deficiency. Acta Med Austriaca 1992;1:110-116.
16. Lavado-Autric R, Ausó E, García-Velasco JV, Arufe MC, Escobar del Rey F, Berbel P, Morreale de Escobar G: Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest 2003;111:1073-1082.
17. Auso E, Lavado-Autric R, Cuevas E, Del Rey FE, Morreale De Escobar G, Berbel P: A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 2004;145:4037-4047.
18. Yasuda T, Ohnishi H, Wataki K, Minagava M, Minamitani K, Niimi H: Outcome of a baby born from a mother with acquired juvenila hypothyroidism having undetectable thyroid hormone concentrations. J Clin Endocrinol Metab 1999;84:2630-2632.
19. Calvo RM, Jauniaux E, Gulbis B, Asunción M, Gervy C, Contempré B, Morreale de Escobar G: Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. Possible consequences of maternal hypothyroxinemia. J Clin Endocrinol Metab 2002;87:1768-1777.
20. Thorpe-Beeston JG, Nicolaides KH, Felton CV, Butler J, McGregor AM: Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 1991;324:532-536.
21. Ferreiro B, Bernal J, Goodyer CG, Branchard CL: Estimation of nuclear thyroid hormone receptor saturation in human fetal brain and lung during early gestation. J Clin Endocrinol Metab 1988;67:853-856.
22. Kester MH, Martinez de Mena R, Obregon MJ, Marinkovic D, Howatson A, Visser TJ, Hume R, Morreale de Escobar G: Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 2004;89:3117-3128.
23. van den Hove MF, Beckers C, Devlieger H, de Zegher F, De Nayer P: Hormone synthesis and storage in the thyroid of human preterm and term newborns: effect of thyroxine treatment. Biochimie 1999;81:563-570.
24. Vulsma T, Gons MH, de Vijlder JJM: Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989;321:13-16.
25. Marin-Padilla M: Dual origin of the mammalian neocortex and evolution of the cortical plate. Anat Embryol (Berl) 1978;152:109-126.
26. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR: Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000;343:378-384.
27. Cole FS: Extremely preterm birth - defining the limits of hope. N Engl J Med 2000;343:429-430.
28. Den Ouden AL, Kok JH, Verkerk PH, Brand R, Verloove-Vanhorick SP: The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res 1996;39:142-145.
29. Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M: The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996;334:821-827.
30. Williams FL, Simpson J, Delahunty C, Ogston SA, Bongers-Schokking JJ, Murphy N, van Toor H, Wu SY, Visser TJ, Hume R: Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab 2004;89:5314-5320.
31. van Wassenaer AG, Westera J, Houtzager BA, Kok JH: Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial. Pediatrics 2005;116:e613-e618.
32. La Gamma E, van Wassenaer A, Golombek SG, Morreale de Escobar G, Kok J, Quero J, Ares S, Paneth N, Fisher DA: Neonatal supplementation for transient hypothyroxinemia of prematurity (THOP): beneficial or detrimental? Treat Endocrinol 2006;5:335-346.
33. Morreale de Escobar G, Ares S: The hypothyroxinemia of prematurity. J Clin Endocrinol Metab 1998;83:713-716.